Close Menu
Daily Guardian
  • Home
  • News
  • Politics
  • Business
  • Entertainment
  • Lifestyle
  • Health
  • Sports
  • Technology
  • Climate
  • Auto
  • Travel
  • Web Stories
What's On

Squamish Search and Rescue called out to look for missing woman

August 21, 2026

HoverAir’s transforming modular drone has already been halted in the US

August 21, 2026

New Crypto Pepeto Announces Crossing 41,000 Buyers Fast as the BNB Price Prediction Targets $1,755

August 21, 2026

Ontario Premier Doug Ford silent on request to restock American alcohol

August 21, 2026

Over 1 million people have clicked LinkedIn’s AI slop button

August 21, 2026
Facebook X (Twitter) Instagram
Finance Pro
Facebook X (Twitter) Instagram
Daily Guardian
Subscribe
  • Home
  • News
  • Politics
  • Business
  • Entertainment
  • Lifestyle
  • Health
  • Sports
  • Technology
  • Climate
  • Auto
  • Travel
  • Web Stories
Daily Guardian
Home » Formulation Development Outsourcing Market Report 2026
Press Release

Formulation Development Outsourcing Market Report 2026

By News RoomMay 11, 20263 Mins Read
Formulation Development Outsourcing Market Report 2026
Share
Facebook Twitter LinkedIn Pinterest Email

Dublin, May 11, 2026 (GLOBE NEWSWIRE) — The “Formulation Development Outsourcing Market Report 2026” has been added to ResearchAndMarkets.com’s offering.

The formulation development outsourcing market is poised for dynamic growth, forecasted to expand from $32.32 billion in 2025 to $35.45 billion in 2026 at a 9.7% CAGR. This surge is driven by complex pharmaceutical R&D, more drug candidates, specialized expertise demands, and heightened regulatory scrutiny. By 2030, the market is expected to reach $53.3 billion, driven by the rising demand for biologics, personalized medicine, and advanced formulation technologies, maintaining a CAGR of 10.7%.

The industry is witnessing a shift towards the outsourcing of complex drug formulations, adopting quality by design (QbD) approaches, and a growing need for injectable and specialized dosage forms. Companies are expanding scale-up and technology transfer services to maintain regulatory compliance and meet accelerated time-to-market demands.

The upward trend in drug demand, underscored by a 13.5% increase in EU exports of medicinal products in 2024, is fueling market growth. Formulation development outsourcing is essential in biopharmaceutical development, enhancing drug delivery systems and offering cost-effective solutions for pharmaceutical firms.

Innovative solutions, like AI-powered generative cloud platforms, are transformative for the industry. Such platforms expedite molecular design, drug discovery, and other R&D functions. NVIDIA’s BioNeMo Cloud, launched in 2023, exemplifies this innovation, offering pre-trained AI models for research acceleration. This service is already adopted by leaders like Amgen to drive efficient, data-driven innovation.

In April 2024, CoreRx, Inc. acquired Societal CDMO Inc., enhancing its capabilities in formulation development and scale-up manufacturing to better serve pharmaceutical clients. This acquisition supports CoreRx’s strategy to offer integrated development-to-commercial manufacturing services.

Key players in this thriving market include Syngene International Ltd., Aizant Drug Research Solutions, Catalent Inc., Intertek Group plc, Recipharm AB, and many others. These companies are central to the market’s expansion, offering critical services like ingredient sourcing, stability studies, and regulatory support.

North America led the global market in 2025, with major regions such as Asia-Pacific, Europe, and Africa also seeing significant activity. The market’s revenues are generated from direct sales, grants, and more, focused on service provision instead of resales. With a continual push towards innovation and efficiency in drug development processes, the formulation development outsourcing market stands as a cornerstone of the global pharmaceutical landscape.

Key Attributes:

Report Attribute Details
No. of Pages 250
Forecast Period 2026 – 2030
Estimated Market Value (USD) in 2026 $35.45 Billion
Forecasted Market Value (USD) by 2030 $53.3 Billion
Compound Annual Growth Rate 10.7%
Regions Covered Global


Major Trends

  • Increasing Outsourcing of Complex Drug Formulations
  • Rising Adoption of Quality by Design Approaches
  • Growing Demand for Injectable and Specialized Dosage Forms
  • Expansion of Scale-Up and Technology Transfer Services
  • Enhanced Focus on Regulatory-Compliant Formulation Development

Companies Featured

  • Syngene International Ltd.
  • Aizant Drug Research Solutions Private Limited.
  • Catalent Inc.
  • Intertek Group PLC
  • Recipharm AB
  • SGS S.A.
  • Lonza Group AG
  • Eurofins Scientific SE
  • Laboratory Corporation of America Holdings
  • Charles River Laboratories International Inc.
  • Piramal Pharma Limited.
  • Quotient Sciences Ltd.
  • Almac Group
  • Patheon
  • Evonik Industries AG
  • Metrics Contract Services
  • Aenova Group
  • Fareva Group
  • Vetter Pharma International GmbH
  • Aesica Pharmaceuticals
  • WuXi AppTec
  • Formosa Laboratories Inc.
  • Aptuit LLC
  • ProPharma Group
  • Laurus Labs Limited

For more information about this report visit https://www.researchandmarkets.com/r/jfpte6

About ResearchAndMarkets.com
ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

  • Formulation Development Outsourcing Market

            
Share. Facebook Twitter Pinterest LinkedIn Tumblr Email

Keep Reading

New Crypto Pepeto Announces Crossing 41,000 Buyers Fast as the BNB Price Prediction Targets $1,755

Crypto News: Pepeto Update On Binance Debut And Ethereum Price Prediction Targets $10,000

Crypto News: Pepeto DeFi Tools Update While Bitcoin Price Might Reach $150,000

Negative Link Announces Global Expansion and Next Phase of Growth

Bioengineered blood vessel for Coronary Bypass Sustains 18-Month Patency — With a Full Year without Blood Thinners

Crypto News: Pepeto Announces Nearing of Second Major Exchange Debut

TheBestReputation Named Among the Best Reputation Management Companies of 2026

MedPro Healthcare Staffing Named Among Largest Healthcare Staffing Firms in the U.S. by Staffing Industry Analysts

Rabofund Expands Simulated Trading Offering With Four Evaluation Models Designed for Different Trader Profiles

Editors Picks

HoverAir’s transforming modular drone has already been halted in the US

August 21, 2026

New Crypto Pepeto Announces Crossing 41,000 Buyers Fast as the BNB Price Prediction Targets $1,755

August 21, 2026

Ontario Premier Doug Ford silent on request to restock American alcohol

August 21, 2026

Over 1 million people have clicked LinkedIn’s AI slop button

August 21, 2026

Latest News

Crypto News: Pepeto Update On Binance Debut And Ethereum Price Prediction Targets $10,000

August 21, 2026

Prince George emergency landing caused by plane’s engine losing power

August 21, 2026

Crypto News: Pepeto DeFi Tools Update While Bitcoin Price Might Reach $150,000

August 21, 2026
Facebook X (Twitter) Pinterest TikTok Instagram
© 2026 Daily Guardian Canada. All Rights Reserved.
  • Privacy Policy
  • Terms
  • Advertise
  • Contact

Type above and press Enter to search. Press Esc to cancel.

Go to mobile version